Methods and organisms for converting synthesis gas or other gaseous carbon sources and methanol to 1,3-butanediol

US9284581B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9284581-B2
Application numberUS-201213597095-A
CountryUS
Kind codeB2
Filing dateAug 28, 2012
Priority dateDec 10, 2009
Publication dateMar 15, 2016
Grant dateMar 15, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A non-naturally occurring microbial organism having a 1,3-butanediol (1,3-BDO) pathway includes at least one exogenous nucleic acid encoding a 1,3-BDO pathway enzyme or protein expressed in a sufficient amount to produce 1,3-BDO. A method for producing 1,3-BDO that includes culturing the this non-naturally occurring microbial organism under conditions and for a sufficient period of time to produce 1,3-BDO.

First claim

Opening claim text (preview).

What is claimed is: 1. A non-naturally occurring microbial organism comprising: (1) a Wood-Ljungdahl pathway, wherein said microbial organism comprises at least one exogenous nucleic acid encoding a Wood-Ljungdahl pathway enzyme expressed in a sufficient amount to enhance carbon flux through acetyl-CoA, wherein said Wood-Ljungdahl pathway enzyme is selected from the group consisting of: a) a formate dehydrogenase that catalyzes the incorporation of CO2 into formate; b) a formyltetrahydrofolate synthetase that ligates formate to tetrahydrofolate to form 10-formyltetrahydrofolate, c) a methenyltetrahydrofolate cyclohydrolase that converts 10-formyltetrahydrofolate to methyltetrahydrofolate, d) a methylenetetrahydrofolate dehydrogenase that converts methyltetrahydrofolate to methenyltetrahydrofolate, e) a methylenetetrahydrofolate reductase that converts metheneyltetrahydrofolate to 5-methyltetrahydrofolate; f) a methyltetrahydrofolate:corrinoid protein methyltransferase that catalyzes the transfer of a methyl group from 5-methyltetrahydrofolate to corrinoid iron sulfur protein, g) a corrinoid iron-sulfur protein, h) a nickel-protein assembly protein, i) a ferredoxin, j) a acetyl-CoA synthase that catalyzes the condensation of the methylated corrinoid iron sulfur protein, carbon monoxide and coenzyme A, yielding acetyl-CoA, k) a carbon monoxide dehydrogenase that converts CO and water to CO2 while passing the electrons to a reduced acceptor, l) a pyruvate ferredoxin oxidoreductase that converts the pyruvate to acetyl-CoA or pyruvate dehydrogenase that converts the pyruvate to acetyl-CoA, and m) a pyruvate formate lyase that converts the pyruvate and CoA to acetyl-CoA; and (2) a 1,3-butanediol pathway that converts acetyl-CoA to 1,3-butanediol, wherein the 1,3-butanediol pathway comprises at least three enzymes selected from the group consisting of: a) an acetoacetyl-CoA thiolase that converts acetyl-CoA to acetoacetyl-CoA, b) an acetoacetyl-CoA reductase (CoA-dependent, alcohol forming) that converts acetoacetyl-CoA to 4-hydroxy,2-butanone, c) a 3-oxobutyraldehyde reductase (aldehyde reducing) that converts 3-oxobutyraldehyde into 4-hydroxybutanone, d) a 4-hydroxy,2-butanone reductase that converts 4-hydroxy,2-butanone to 1,3-butanediol, e) an acetoacetyl-CoA reductase (CoA-dependent, aldehyde forming) that converts acetoacetyl-CoA to 3-oxobutyraldehyde, f) a 3-oxobutyraldehyde reductase (ketone reducing) that converts 3-oxobutyraldehyde to 3-hydroxybutyraldehyde, g) a 3-hydroxybutyraldehyde reductase that converts 3-hydroxybutyraldehyde to 1,3-BDO, h) an acetoacetyl-CoA reductase (ketone reducing) that converts acetoacetyl-CoA to 3-hydroxybutyryl-CoA, i) a 3-hydroxybutyryl-CoA reductase (aldehyde forming) that converts 3-hydroxybutyryl-CoA to 3-hydroxybutyraldehyde, j) a 3-hydroxybutyryl-CoA reductase (alcohol forming) that converts 3-hydroxybutyryl-CoA to 1,3-butanediol, k) an acetoacetyl-CoA transferase, an acetoacetyl-CoA hydrolase, an acetoacetyl-CoA synthetase, or a phosphotransacetoacetylase/acetoacetate kinase that converts acetoacetyl-CoA to acetoacetate, l) an acetoacetate reductase that converts acetoacetate to 3-oxobutyraldehyde, m) a 3-hydroxybutyryl-CoA transferase, a 3-hydroxybutyryl-CoA hydrolase, or a 3-hydroxybutyryl-CoA synthetase that converts 3-hydroxybutyryl-CoA to 3-hydroxybutyrate, n) a 3-hydroxybutyrate reductase that converts 3-hydroxybutyrate to 3-hydroxybutyraldehyde; and o) a 3-hydroxybutyrate dehydrogenase that converts acetoacetate to 3-hydroxybutyrate. 2. The non-naturally occurring microbial organism of claim 1 , wherein the organism comprises exogenous nucleic acids encoding each of the Wood-Ljungdahl pathway enzymes (a)-(m). 3. The non-naturally occurring microbial organism of claim 1 , wherein at least one of the 1,3-BDO pathway enzymes is encoded by an exogenous nucleic acid. 4. The non-naturally occurring microbial organism of claim 1 , wherein said at least one exogenous nucleic acid is a heterologous nucleic acid. 5. The non-naturally occurring microbial organism of claim 1 , wherein said non-naturally occurring microbial organism is in a substantially anaerobic culture medium. 6. The non-naturally occurring microbial organism of claim 1 , wherein said microbial organism uses a carbon feedstock selected from 1) methanol and CO, 2) methanol, CO 2 , and H 2 , 3) methanol, CO, CO 2 , and H 2 , 4) methanol and synthesis gas comprising CO and H 2 , 5) methanol and synthesis gas comprising CO, CO 2 , and H 2 , 6) one or more carbohydrates, 7) methanol and one or more carbohydrates, and 8) methanol. 7. A method for producing 1,3-BDO, comprising culturing the organism of claim 1 under conditions and for a sufficient period of time to produce 1,3-BDO. 8. A culture medium comprising 1,3-BDO produced according to the method of claim 7 . 9. The culture medium of claim 8 , wherein said culture medium is separated from the non-naturally occurring microbial organism. 10. A composition comprising a biosynthesized 1,3-BDO and the non-naturally occurring microbial organism of claim 1 . 11. A biosynthesized 1,3-BDO produced according to the method of claim 7 .

Assignees

Inventors

Classifications

  • C12P7/18Primary

    polyhydric · CPC title

  • Genes encoding for enzymes or proenzymes · CPC title

  • Biofuels, e.g. bio-diesel · CPC title

  • Butanols · CPC title

  • C12N1/20Primary

    Bacteria; Culture media therefor · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9284581B2 cover?
A non-naturally occurring microbial organism having a 1,3-butanediol (1,3-BDO) pathway includes at least one exogenous nucleic acid encoding a 1,3-BDO pathway enzyme or protein expressed in a sufficient amount to produce 1,3-BDO. A method for producing 1,3-BDO that includes culturing the this non-naturally occurring microbial organism under conditions and for a sufficient period of time to prod…
Who is the assignee on this patent?
Burgard Anthony P, Burk Mark J, Pharkya Priti, and 1 more
What technology area does this patent fall under?
Primary CPC classification C12P7/18. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Mar 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).